(ROG) Roche Holding - Ratings and Ratios
Exchange: SW • Country: Switzerland • Currency: CHF • Type: Common Stock • ISIN: CH0012032048
ROG: Medicines, Diagnostics, Tests, Instruments, Solutions
Roger that, let me rephrase this description of Roche Holding AG with more details and in a more engaging way, as per your request.
Roger that, let me rephrase this description of Roche Holding AG with more details and in a more engaging way, as per your request.
Roger that, let me rephrase this description of Roche Holding AG with more details and in a more engaging way, as per your request.
Additional Sources for ROG Stock
ROG Stock Overview
| Market Cap in USD | 282,199m |
| Sector | Healthcare |
| Industry | Drug Manufacturers - General |
| GiC Sub-Industry | Pharmaceuticals |
| IPO / Inception |
ROG Stock Ratings
| Growth 5y | 6.05% |
| Fundamental | 57.7% |
| Dividend | 57.9% |
| Rel. Strength Industry | 31.5 |
| Analysts | - |
| Fair Price Momentum | 328.17 CHF |
| Fair Price DCF | 571.51 CHF |
ROG Dividends
| Dividend Yield 12m | 3.41% |
| Yield on Cost 5y | 3.73% |
| Annual Growth 5y | 1.30% |
| Payout Consistency | 98.8% |
ROG Growth Ratios
| Growth Correlation 3m | 98.1% |
| Growth Correlation 12m | 73.7% |
| Growth Correlation 5y | -48.5% |
| CAGR 5y | 3.15% |
| CAGR/Max DD 5y | 0.07 |
| Sharpe Ratio 12m | 2.70 |
| Alpha | 30.77 |
| Beta | 0.03 |
| Volatility | 18.61% |
| Current Volume | 1164.8k |
| Average Volume 20d | 1289.1k |
What is the price of ROG stocks?
As of March 25, 2025, the stock is trading at CHF 304.20 with a total of 1,164,848 shares traded.
Over the past week, the price has changed by -2.22%, over one month by +2.05%, over three months by +19.95% and over the past year by +34.90%.
As of March 25, 2025, the stock is trading at CHF 304.20 with a total of 1,164,848 shares traded.
Over the past week, the price has changed by -2.22%, over one month by +2.05%, over three months by +19.95% and over the past year by +34.90%.
Is Roche Holding a good stock to buy?
Partly, yes. Based on ValueRay Fundamental Analyses, Roche Holding (SW:ROG) is currently (March 2025) ok to buy, but has to be watched. It has a ValueRay Fundamental Rating of 57.69 and therefor a somewhat positive outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of ROG as of March 2025 is 328.17. This means that ROG is currently overvalued and has a potential downside of 7.88%.
Partly, yes. Based on ValueRay Fundamental Analyses, Roche Holding (SW:ROG) is currently (March 2025) ok to buy, but has to be watched. It has a ValueRay Fundamental Rating of 57.69 and therefor a somewhat positive outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of ROG as of March 2025 is 328.17. This means that ROG is currently overvalued and has a potential downside of 7.88%.
Is ROG a buy, sell or hold?
Roche Holding has no consensus analysts rating.
Roche Holding has no consensus analysts rating.
What are the forecast for ROG stock price target?
According to ValueRays Forecast Model, ROG Roche Holding will be worth about 354.4 in March 2026. The stock is currently trading at 304.20. This means that the stock has a potential upside of +16.51%.
According to ValueRays Forecast Model, ROG Roche Holding will be worth about 354.4 in March 2026. The stock is currently trading at 304.20. This means that the stock has a potential upside of +16.51%.
| Issuer | Forecast | Upside |
|---|---|---|
| Wallstreet Target Price | 315 | 3.6% |
| Analysts Target Price | - | - |
| ValueRay Target Price | 354.4 | 16.5% |